Our top pick for
NI Holdings, Inc is an insurance-property & casualty business based in the US. NI shares (NODK) are listed on the NASDAQ and all prices are listed in US Dollars. NI employs 186 staff and has a trailing 12-month revenue of around USD$294 million.
|52-week range||USD$10.15 - USD$18.1702|
|50-day moving average||USD$17.1232|
|200-day moving average||USD$16.8339|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.624|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing NI stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NI's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NI's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, NI shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
NI's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$46.5 million.
The EBITDA is a measure of a NI's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$294 million|
|Operating margin TTM||15.45%|
|Gross profit TTM||USD$33.8 million|
|Return on assets TTM||4.9%|
|Return on equity TTM||11.67%|
|Market capitalisation||USD$381.6 million|
TTM: trailing 12 months
There are currently 61,713 NI shares held short by investors – that's known as NI's "short interest". This figure is 1.5% up from 60,807 last month.
There are a few different ways that this level of interest in shorting NI shares can be evaluated.
NI's "short interest ratio" (SIR) is the quantity of NI shares currently shorted divided by the average quantity of NI shares traded daily (recently around 15125.735294118). NI's SIR currently stands at 4.08. In other words for every 100,000 NI shares traded daily on the market, roughly 4080 shares are currently held short.
However NI's short interest can also be evaluated against the total number of NI shares, or, against the total number of tradable NI shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NI's short interest could be expressed as 0% of the outstanding shares (for every 100,000 NI shares in existence, roughly 0 shares are currently held short) or 0.0072% of the tradable shares (for every 100,000 tradable NI shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NI.
Find out more about how you can short NI stock.
We're not expecting NI to pay a dividend over the next 12 months.
Over the last 12 months, NI's shares have ranged in value from as little as $10.15 up to $18.1702. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NI's is 0.2208. This would suggest that NI's shares are less volatile than average (for this exchange).
NI Holdings, Inc. underwrites property and casualty insurance products in North Dakota, South Dakota, Nebraska, Minnesota, Nevada, Arizona, and Illinois. The company's products include multi-peril crop, crop hail, private passenger automobile, farm owners, homeowners, and commercial property and liability insurance policies, as well as non-standard automobile insurance products. It distributes its insurance products through independent producers and independent agents. The company was founded in 1946 and is headquartered in Fargo, North Dakota. NI Holdings, Inc. operates as a subsidiary of Nodak Mutual Group, Inc.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.